Intranasal Therapeutics

About:

Ikano Therapeutics a specialty pharmaceutical company, focuses on developing nasal spray drug products.

Top Investors: F-Prime Capital, SV Health Investors, Eight Roads Ventures, Fort Washington Capital Partners Group, Tullis Health Investors

Description:

Total Funding Amount:

$60.2M

Headquarters Location:

Montvale, New Jersey, United States

Founded Date:

1998-01-01

Founders:

Edwin Cohen

Number of Employees:

251-500

Last Funding Date:

2009-03-30

IPO Status:

Private

Industries: